FDA 483 - CSL Plasma Inc. - February 01, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
CSL Plasma Inc. in Dallas, TX, a plasmapheresis center, was cited for failing to follow its written standard operating procedures for the storage and disposition of blood and blood components. Specifically, units from donors who tested reactive for RTTIs were found to remain in "inventory" status, indicating they were retrievable despite being unsuitable. This represents a significant lapse in quality control and adherence to internal procedures for managing potentially unsafe blood products.
ID · e4f9a6fa-0206-4a82-8f69-c39c28ec6c00